Repare Therapeutics Ownership | Who Owns Repare Therapeutics?
Repare Therapeutics Ownership Summary
Repare Therapeutics is owned by 16.84% institutional investors, 0.25% insiders, and 82.90% retail investors. Aquilo capital management is the largest institutional shareholder, holding 3.05% of RPTX shares. ARK Genomic Revolution ETF is the top mutual fund, with 2.65% of its assets in Repare Therapeutics shares.
RPTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Repare Therapeutics | 16.84% | 0.25% | 82.90% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Aquilo capital management | 1.29M | 3.05% | $1.69M |
| Mpm asset management | 1.12M | 2.61% | $1.97M |
| Bioimpact capital | 819.92K | 1.91% | $1.44M |
| Millennium management | 170.96K | 0.40% | $223.96K |
| Blackrock | 141.80K | 0.34% | $467.95K |
| Militia capital partners, lp | 119.18K | 0.28% | $209.75K |
| Two sigma advisers, lp | 27.70K | 0.06% | $48.75K |
| Blackstone | 25.96K | 0.06% | $45.68K |
| Bank of america corp /de/ | 10.25K | 0.02% | $33.84K |
| Citadel advisors | 1.40K | 0.00% | $4.62K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Mpm asset management | 1.12M | 4.43% | $1.97M |
| Aquilo capital management | 1.29M | 2.56% | $1.69M |
| Bioimpact capital | 819.92K | 0.24% | $1.44M |
| Militia capital partners, lp | 119.18K | 0.10% | $209.75K |
| Blackstone | 25.96K | 0.00% | $45.68K |
| Millennium management | 170.96K | 0.00% | $223.96K |
| Two sigma advisers, lp | 27.70K | 0.00% | $48.75K |
| Renaissance | - | - | - |
| Pdt partners | - | - | - |
| National bank of canada /fi/ | - | - | - |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Aquilo capital management | 1.29M | 2.56% | 304.35K |
| Blackrock | 141.80K | - | 80.54K |
| Millennium management | 170.96K | 0.00% | 67.64K |
| Blackstone | 25.96K | 0.00% | - |
| Two sigma advisers, lp | 27.70K | 0.00% | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Bvf inc/il | - | - | -10.33M |
| Blue owl capital lp | - | - | -3.44M |
| Orbimed advisors | - | - | -3.32M |
| Versant venture management | - | - | -2.65M |
| Redmile group | - | - | -1.59M |
Sold Out
| Holder | Change |
|---|---|
| Bnp paribas arbitrage, snc | -1.00 |
| Jpmorgan chase | -4.00 |
| Steward partners investment advisory | -11.00 |
| Jones financial companies lllp | -100.00 |
| Royal bank of canada | -200.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | 28 | -37.78% | 7,235,847 | -73.47% | 16 | 0.42% | 12 | - | 5 | - |
| Sep 30, 2025 | 22 | -53.19% | 8,070,778 | -69.88% | 18 | 0.48% | 3 | -81.25% | 2 | -80.00% |
| Jun 30, 2025 | 51 | 4.08% | 27,751,924 | 7.80% | 64 | 1.77% | 19 | - | 10 | -33.33% |
| Mar 31, 2025 | 51 | -5.56% | 29,511,633 | -3.64% | 69 | 1.33% | 20 | - | 16 | -15.79% |
| Dec 31, 2024 | 24 | -57.89% | 6,082,941 | -81.22% | 14 | 0.25% | 9 | -52.63% | 7 | -61.11% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Genomic Revolution ETF | 1.13M | 2.65% | -1.65K |
| ARK Genomic Revolution | 1.10M | 2.59% | -872.23K |
| Nikko Gbl All Biological Genome Eq MF | 297.64K | 0.70% | -28.36K |
| A4Investments SICAV SIF ACCI IlanaA2EURH | 160.00K | 0.38% | - |
| Northern Small Cap Core I | 77.83K | 0.18% | -5.85K |
| Vanguard Health Care ETF | 52.52K | 0.12% | 231.00 |
| Biotech Growth Ord | 49.26K | 0.11% | - |
| Range Cancer Therapeutics ETF | 47.41K | 0.11% | - |
| Vifag 2002 SICAV | 35.00K | 0.08% | - |
| NT Quality SCC US Fund - L | 23.17K | 0.05% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 12, 2025 | Koehler Maria | EVP, CHIEF MEDICAL OFFICER | Sell | $4.10K |
| Mar 12, 2025 | Zinda Michael | EVP, CHIEF SCIENTIFIC OFFICER | Sell | $6.40K |
| Mar 12, 2025 | Forte Steve | EVP, CHIEF FINANCIAL OFFICER | Sell | $7.85K |
| Mar 12, 2025 | Segal Lloyd Mitchell | PRESIDENT AND CEO | Sell | $24.14K |
| Mar 28, 2024 | Segal Lloyd Mitchell | PRESIDENT AND CEO | Sell | $12.24K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q1 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | - | 4 |
| 2024 Q2 | - | 4 |
| 2024 Q1 | - | 16 |
RPTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools